Ever since health officials announced Canada’s first known case of rare, post-vaccination blood clots back in April, scientists have been racing to learn more about what causes the potentially deadly condition — and how to treat it.
Now, a team from McMaster University in Hamilton has published new research-backed recommendations calling on clinicians to use a combination of two treatments: anti-clotting drugs alongside high doses of an intravenous, antibody-based therapy.
WNews is the place to be for the latest global news. Started in 2014, we want to bring the news back to the news with unbiased reporting of the news. We believed that news should be honest and trustworthy.
WNews is a W-World Brand, a Canadian-based company.